publication date: Dec. 19, 2010
In this issue:
Feds set guidelines for pharma to help patients with cost of drugs, while steering clear of anti-kickback law.
Advocacy groups consider pros and cons of forming co-pay foundations.
Download (PDF 719KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.